Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials

Research output: Contribution to journal › Article › Academic › peer-review

329 Citations (Scopus)

Research programs

@article{03af4ac52c6142ba8933f19c1c04ee16,

title = "Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials",

author = "K Wheatley and N Ives and B Hancock and M Gore and Lex Eggermont and S Suciu",

year = "2003",

doi = "10.1016/S0305-7372(03)00074-4",

language = "Undefined/Unknown",

volume = "29",

pages = "241--252",

journal = "Cancer Treatment Reviews",

issn = "0305-7372",

number = "4",

}

TY - JOUR

T1 - Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials

AU - Wheatley, K

AU - Ives, N

AU - Hancock, B

AU - Gore, M

AU - Eggermont, Lex

AU - Suciu, S

PY - 2003

Y1 - 2003

U2 - 10.1016/S0305-7372(03)00074-4

DO - 10.1016/S0305-7372(03)00074-4

M3 - Article

SN - 0305-7372

VL - 29

SP - 241

EP - 252

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

IS - 4

ER -